Effects of resistance exercise on cognitive performance in people with type 1 diabetes
The Effects of Resistance Exercise on Cognition in People With Type 1 Diabetes: a Randomised Controlled Trial
NA · Dasman Diabetes Institute · NCT05963152
This study is testing how different types of resistance exercise can affect thinking skills in people with type 1 diabetes.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 54 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Dasman Diabetes Institute (other) |
| Locations | 1 site (Kuwait City) |
| Trial ID | NCT05963152 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate how resistance exercise influences cognitive performance in individuals with type 1 diabetes. Participants will engage in different exercise regimens, including habitual physical activity, morning exercise, and afternoon exercise. The primary focus is on assessing performance in cognitive tests such as the Paced Auditory Serial Addition Test and the Colour Trails Test. The study seeks to provide insights into the relationship between physical activity and cognitive function in this population.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with type 1 diabetes for at least one year and on stable insulin therapy.
Not a fit: Patients with severe obesity, high blood pressure, or other medical conditions that prevent safe exercise may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance cognitive function in patients with type 1 diabetes through targeted exercise interventions.
How similar studies have performed: While there is emerging evidence on the benefits of exercise for cognitive function in various populations, this specific approach in type 1 diabetes is relatively novel and less explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Physician confirmed type 1 diabetes for at least 1 year * Stable insulin therapy for 3 months prior to the study Exclusion Criteria: * BMI of 45 or higher * BP of 160/100mmHg or higher * autonomic neuropathy * severe proliferative retinopathy * joint or limb injuries preventing weight-bearing activity * autonomic neuropathy * severe proliferative retinopathy * any other medical condition that prevents participants from exercising safely.
Where this trial is running
Kuwait City
- Dasman Diabetes Institute — Kuwait City, Kuwait (RECRUITING)
Study contacts
- Study coordinator: Ebaa AlOzairi
- Email: ebaa.alozairi@dasmaninstitute.rog
- Phone: +965 22242999
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: type1diabetes, exercise, cognition